Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

FHS
May 3, 2024
10:30 am

Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs).

Innovative research identifies key genes in cassava whitefly management

Whiteflies, particularly the African cassava whitefly (Bemisia tabaci, SSA1-SG1), pose a significant threat to agricultural productivity in Sub-Saharan Africa by transmitting viruses that cause cassava

February 24, 2024

Healthcare 2024 Second Half Outlook

The S&P Healthcare Index rose 6% in the first half of the year, while the Prudent Healthcare model portfolio gained 25%. While the healthcare index

August 2, 2024

Early sepsis detection: molecular immune markers show limited impact in screening tools

Researchers evaluated the additional predictive value of molecular immune markers with the Predict Sepsis screening tools developed previously by the same research team.

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.